213 related articles for article (PubMed ID: 23287860)
21. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.
Marin MC; Hsu B; Stephens LC; Brisbay S; McDonnell TJ
Exp Cell Res; 1995 Apr; 217(2):240-7. PubMed ID: 7698223
[TBL] [Abstract][Full Text] [Related]
22. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability.
Luke JJ; Van De Wetering CI; Knudson CM
Cell Death Differ; 2003 Jun; 10(6):740-8. PubMed ID: 12761582
[TBL] [Abstract][Full Text] [Related]
23. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.
Jacobs JJ; Scheijen B; Voncken JW; Kieboom K; Berns A; van Lohuizen M
Genes Dev; 1999 Oct; 13(20):2678-90. PubMed ID: 10541554
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival.
Arrate MP; Vincent T; Odvody J; Kar R; Jones SN; Eischen CM
Cancer Res; 2010 Jul; 70(14):6083-92. PubMed ID: 20587524
[TBL] [Abstract][Full Text] [Related]
25. Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma.
Kelly PN; Puthalakath H; Adams JM; Strasser A
Blood; 2007 Jun; 109(11):4907-13. PubMed ID: 17317859
[TBL] [Abstract][Full Text] [Related]
26. Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis.
Nguyen HV; Vandenberg CJ; Ng AP; Robati MR; Anstee NS; Rimes J; Hawkins ED; Cory S
Blood; 2020 Mar; 135(13):1019-1031. PubMed ID: 31978211
[TBL] [Abstract][Full Text] [Related]
27. Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis.
Vasanthakumar A; Lepore JB; Zegarek MH; Kocherginsky M; Singh M; Davis EM; Link PA; Anastasi J; Le Beau MM; Karpf AR; Godley LA
Blood; 2013 Mar; 121(11):2059-63. PubMed ID: 23315164
[TBL] [Abstract][Full Text] [Related]
28. Loss of PRDM11 promotes MYC-driven lymphomagenesis.
Fog CK; Asmar F; Côme C; Jensen KT; Johansen JV; Kheir TB; Jacobsen L; Friis C; Louw A; Rosgaard L; Øbro NF; Marquart HV; Anthonsen K; Braat AK; van Lohuizen M; Ralfkiaer E; Grønbæk K; Lund AH
Blood; 2015 Feb; 125(8):1272-81. PubMed ID: 25499759
[TBL] [Abstract][Full Text] [Related]
29. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers.
Li Y; Chitnis N; Nakagawa H; Kita Y; Natsugoe S; Yang Y; Li Z; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA
Cancer Discov; 2015 Mar; 5(3):288-303. PubMed ID: 25582697
[TBL] [Abstract][Full Text] [Related]
30. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
31. Bif-1/endophilin B1: a candidate for crescent driving force in autophagy.
Takahashi Y; Meyerkord CL; Wang HG
Cell Death Differ; 2009 Jul; 16(7):947-55. PubMed ID: 19265852
[TBL] [Abstract][Full Text] [Related]
32. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis.
Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB
Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382
[TBL] [Abstract][Full Text] [Related]
33. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
[TBL] [Abstract][Full Text] [Related]
34. BARgaining membranes for autophagosome formation: Regulation of autophagy and tumorigenesis by Bif-1/Endophilin B1.
Takahashi Y; Meyerkord CL; Wang HG
Autophagy; 2008 Jan; 4(1):121-4. PubMed ID: 18032918
[TBL] [Abstract][Full Text] [Related]
35. Transgenic overexpression of a dominant negative mutant of FADD that, although counterselected during tumor progression, cooperates in L-myc-induced tumorigenesis.
Hueber AO; Bösser S; Zörnig M
Int J Cancer; 2004 Nov; 112(3):536-40. PubMed ID: 15382083
[TBL] [Abstract][Full Text] [Related]
36. Bif-1/Endophilin B1/SH3GLB1 regulates bone homeostasis.
Touyama K; Khan M; Aoki K; Matsuda M; Hiura F; Takakura N; Matsubara T; Harada Y; Hirohashi Y; Tamura Y; Gao J; Mori K; Kokabu S; Yasuda H; Fujita Y; Watanabe K; Takahashi Y; Maki K; Jimi E
J Cell Biochem; 2019 Nov; 120(11):18793-18804. PubMed ID: 31243813
[TBL] [Abstract][Full Text] [Related]
37. Bif-1 Interacts with Prohibitin-2 to Regulate Mitochondrial Inner Membrane during Cell Stress and Apoptosis.
Cho SG; Xiao X; Wang S; Gao H; Rafikov R; Black S; Huang S; Ding HF; Yoon Y; Kirken RA; Yin XM; Wang HG; Dong Z
J Am Soc Nephrol; 2019 Jul; 30(7):1174-1191. PubMed ID: 31126972
[TBL] [Abstract][Full Text] [Related]
38. Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation.
Scott CL; Schuler M; Marsden VS; Egle A; Pellegrini M; Nesic D; Gerondakis S; Nutt SL; Green DR; Strasser A
J Cell Biol; 2004 Jan; 164(1):89-96. PubMed ID: 14709542
[TBL] [Abstract][Full Text] [Related]
39. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.
Baechler BL; Bloemberg D; Quadrilatero J
Autophagy; 2019 Sep; 15(9):1606-1619. PubMed ID: 30859901
[TBL] [Abstract][Full Text] [Related]
40. AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation.
Cianfanelli V; Fuoco C; Lorente M; Salazar M; Quondamatteo F; Gherardini PF; De Zio D; Nazio F; Antonioli M; D'Orazio M; Skobo T; Bordi M; Rohde M; Dalla Valle L; Helmer-Citterich M; Gretzmeier C; Dengjel J; Fimia GM; Piacentini M; Di Bartolomeo S; Velasco G; Cecconi F
Nat Cell Biol; 2015 Jan; 17(1):20-30. PubMed ID: 25438055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
